UNICEF initiative makes inactivated polio vaccine more accessible
The tender process is a step toward successfully accomplishing the GPEI's Eradication and Endgame Strategic Plan 2013-2018, an initiative that intends to eradicate polio globally by 2018. The IPV will be available at reduced costs to GAVI-supported countries and middle-income countries through UNICEF in July.
GAVI-supported countries will gain access to the IPV at $1.03 per dose in ten-dose vials. Middle-income countries will be offered IPVs from $2.04 to $3.29 per dose. Orders can also be placed for five-dose vials at $1.90 or single-dose vials for $2.80 in both middle-income and GAVI-supported countries.
The new initiative lowers the cost of the vaccine until 2018, and UNICEF plans to potentially extend the program beyond 2018.
The GPEI's strategic plan calls for the transition from the oral polio vaccine to the IPV by the end of 2015. The new tender process makes the vaccine available to more than 120 countries.
The global use of IPV is supported by the World Health Organization's Strategic Advisory Group of Experts on Immunization and the World Health Assembly.